JP2011528333A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528333A5 JP2011528333A5 JP2011517955A JP2011517955A JP2011528333A5 JP 2011528333 A5 JP2011528333 A5 JP 2011528333A5 JP 2011517955 A JP2011517955 A JP 2011517955A JP 2011517955 A JP2011517955 A JP 2011517955A JP 2011528333 A5 JP2011528333 A5 JP 2011528333A5
- Authority
- JP
- Japan
- Prior art keywords
- human beta
- beta defensin
- composition
- seq
- body weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 8
- 102000000541 Defensins Human genes 0.000 claims 6
- 108010002069 Defensins Proteins 0.000 claims 6
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 claims 6
- 102000055647 human CSF2RB Human genes 0.000 claims 6
- 230000037396 body weight Effects 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
- 101000884714 Homo sapiens Beta-defensin 4A Proteins 0.000 claims 3
- 102000049262 human DEFB4A Human genes 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims 1
- 101000952040 Homo sapiens Beta-defensin 1 Proteins 0.000 claims 1
- 101000912247 Homo sapiens Beta-defensin 103 Proteins 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 102000046975 human DEFB1 Human genes 0.000 claims 1
- 102000055779 human DEFB103A Human genes 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08160761.6 | 2008-07-18 | ||
| EP08160761 | 2008-07-18 | ||
| EP08162486.8 | 2008-08-15 | ||
| EP08162486 | 2008-08-15 | ||
| EP08163614 | 2008-09-03 | ||
| EP08163614.4 | 2008-09-03 | ||
| PCT/EP2009/059253 WO2010007166A2 (en) | 2008-07-18 | 2009-07-17 | Treatment of inflammatory bowel diseases with mammal beta defensins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011144522A Division JP2011225596A (ja) | 2008-07-18 | 2011-06-29 | 哺乳動物のベータ・ディフェンシンを用いた、炎症性腸疾患の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011528333A JP2011528333A (ja) | 2011-11-17 |
| JP2011528333A5 true JP2011528333A5 (enExample) | 2012-04-12 |
Family
ID=41530820
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011517955A Pending JP2011528333A (ja) | 2008-07-18 | 2009-07-17 | 哺乳動物のベータ・ディフェンシンを用いた、炎症性腸疾患の治療 |
| JP2011144522A Pending JP2011225596A (ja) | 2008-07-18 | 2011-06-29 | 哺乳動物のベータ・ディフェンシンを用いた、炎症性腸疾患の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011144522A Pending JP2011225596A (ja) | 2008-07-18 | 2011-06-29 | 哺乳動物のベータ・ディフェンシンを用いた、炎症性腸疾患の治療 |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US8232242B2 (enExample) |
| EP (2) | EP2320930A2 (enExample) |
| JP (2) | JP2011528333A (enExample) |
| KR (1) | KR20110092325A (enExample) |
| CN (2) | CN102247591A (enExample) |
| AP (2) | AP2011005538A0 (enExample) |
| AR (2) | AR072032A1 (enExample) |
| AU (1) | AU2009272681A1 (enExample) |
| BR (2) | BRPI0915973A2 (enExample) |
| CA (2) | CA2730789A1 (enExample) |
| CL (1) | CL2011000099A1 (enExample) |
| EA (2) | EA201100910A1 (enExample) |
| IL (2) | IL210715A0 (enExample) |
| MX (1) | MX2011000568A (enExample) |
| NZ (2) | NZ593653A (enExample) |
| PH (1) | PH12012501542A1 (enExample) |
| SG (1) | SG172709A1 (enExample) |
| TW (2) | TW201004640A (enExample) |
| WO (1) | WO2010007166A2 (enExample) |
| ZA (1) | ZA201100461B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011528334A (ja) * | 2008-07-18 | 2011-11-17 | ノボザイムス アデニウム バイオテック アクティーゼルスカブ | 哺乳動物のベータ・ディフェンシンを用いた、関節リウマチの治療 |
| US20100016232A1 (en) * | 2008-07-18 | 2010-01-21 | Novozymes A/S | Treatment Of Inflammatory Diseases With Mammal Beta Defensins |
| AR072032A1 (es) | 2008-07-18 | 2010-07-28 | Novozymes As | Tratamiento de enfermedades inflamatorias del intestino con beta defensinas de mamiferos |
| KR101320472B1 (ko) * | 2010-06-16 | 2013-10-23 | 주식회사 나이벡 | 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물 |
| EP3501284A1 (en) | 2011-04-15 | 2019-06-26 | Marine Polymer Technologies, Inc. | Treatment of skin deseases with poly-n-acetyl glucosamine nanofibers |
| US9217021B2 (en) | 2011-07-08 | 2015-12-22 | Defensin Therapeutics Aps | Oral treatment of inflammatory bowel disease |
| WO2013026794A1 (en) | 2011-08-19 | 2013-02-28 | Novozymes | Novel immunomodulatory peptide |
| US10257564B2 (en) * | 2013-01-24 | 2019-04-09 | Saturn Licensing Llc | Distributed non-real-time content |
| CN104628864B (zh) * | 2013-11-14 | 2020-04-10 | 中国医学科学院医药生物技术研究所 | 一种抗肿瘤融合蛋白EL-defensin、其编码基因和用途 |
| CN109414474B (zh) * | 2016-04-29 | 2024-07-02 | 诺维信公司 | 肝脏、胆道和胰腺障碍的治疗 |
| SG10202012106WA (en) | 2016-12-13 | 2021-01-28 | Defensin Therapeutics Aps | Methods for treating inflammatory conditions of the lungs |
| CN111556759A (zh) * | 2017-11-10 | 2020-08-18 | 防御素治疗学公司 | 早产儿中的粘膜防御和肠道/肺功能的成熟化 |
| EP3713590B1 (en) | 2017-11-24 | 2025-05-07 | Defensin Therapeutics ApS | Human beta 2 defensin for use in the prevention and treatment of graft-versus-host-disease |
| KR102244161B1 (ko) * | 2018-08-31 | 2021-04-26 | 주식회사 나이벡 | 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도 |
| CN113684162B (zh) * | 2021-06-03 | 2024-02-27 | 江南大学 | 一种表达小鼠防御素mBD14基因的重组植物乳杆菌及其应用 |
| WO2024225153A1 (ja) * | 2023-04-27 | 2024-10-31 | サントリーホールディングス株式会社 | 免疫活性化用組成物 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| DE4343591A1 (de) | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6576755B1 (en) * | 1997-09-10 | 2003-06-10 | Zymogenetics, Inc. | Beta-defensins |
| DE19957043A1 (de) * | 1999-11-26 | 2001-06-07 | Forssmann Wolf Georg | Neue Defensine |
| US7338936B2 (en) * | 2000-11-28 | 2008-03-04 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| US20080194481A1 (en) * | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
| FR2841556B1 (fr) | 2002-07-01 | 2007-07-20 | Centre Nat Rech Scient | Peptides ayant des proprietes antimicrobiennes et les compositions les contenant notamment pour la conservation des aliments |
| JP2006514106A (ja) * | 2002-12-19 | 2006-04-27 | ヒルマン，イチャク | 抗菌ペプチド阻害剤による疾患治療 |
| US20070207209A1 (en) | 2004-08-27 | 2007-09-06 | Murphy Christopher J | Trophic factor combinations for nervous system treatment |
| GB0514482D0 (en) | 2005-07-14 | 2005-08-17 | Ares Trading Sa | Protein |
| WO2007081486A2 (en) | 2005-12-15 | 2007-07-19 | Ventria Bioscience | Oral administration of defensins to treat intestinal diseases |
| CA2676483A1 (en) | 2006-01-24 | 2007-08-02 | University Of Maryland Biotechnology Institute | Surface-layer protein coated microspheres and uses thereof |
| WO2009033776A1 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a defensin peptide as a therapeutic agent |
| US20100016232A1 (en) * | 2008-07-18 | 2010-01-21 | Novozymes A/S | Treatment Of Inflammatory Diseases With Mammal Beta Defensins |
| AR072032A1 (es) | 2008-07-18 | 2010-07-28 | Novozymes As | Tratamiento de enfermedades inflamatorias del intestino con beta defensinas de mamiferos |
| JP2011528334A (ja) | 2008-07-18 | 2011-11-17 | ノボザイムス アデニウム バイオテック アクティーゼルスカブ | 哺乳動物のベータ・ディフェンシンを用いた、関節リウマチの治療 |
| US9217021B2 (en) | 2011-07-08 | 2015-12-22 | Defensin Therapeutics Aps | Oral treatment of inflammatory bowel disease |
| WO2013026794A1 (en) | 2011-08-19 | 2013-02-28 | Novozymes | Novel immunomodulatory peptide |
-
2009
- 2009-07-17 AR ARP090102741A patent/AR072032A1/es not_active Application Discontinuation
- 2009-07-17 EA EA201100910A patent/EA201100910A1/ru unknown
- 2009-07-17 EA EA201170219A patent/EA201170219A1/ru unknown
- 2009-07-17 JP JP2011517955A patent/JP2011528333A/ja active Pending
- 2009-07-17 MX MX2011000568A patent/MX2011000568A/es not_active Application Discontinuation
- 2009-07-17 CN CN201110163184XA patent/CN102247591A/zh active Pending
- 2009-07-17 CA CA2730789A patent/CA2730789A1/en not_active Abandoned
- 2009-07-17 BR BRPI0915973-8A patent/BRPI0915973A2/pt not_active IP Right Cessation
- 2009-07-17 US US12/504,909 patent/US8232242B2/en not_active Expired - Fee Related
- 2009-07-17 NZ NZ593653A patent/NZ593653A/xx not_active IP Right Cessation
- 2009-07-17 AP AP2011005538A patent/AP2011005538A0/xx unknown
- 2009-07-17 NZ NZ590468A patent/NZ590468A/en not_active IP Right Cessation
- 2009-07-17 SG SG2011043452A patent/SG172709A1/en unknown
- 2009-07-17 WO PCT/EP2009/059253 patent/WO2010007166A2/en not_active Ceased
- 2009-07-17 KR KR1020117014574A patent/KR20110092325A/ko not_active Withdrawn
- 2009-07-17 EP EP09780791A patent/EP2320930A2/en not_active Withdrawn
- 2009-07-17 EP EP11182338A patent/EP2399600A1/en not_active Withdrawn
- 2009-07-17 AU AU2009272681A patent/AU2009272681A1/en not_active Abandoned
- 2009-07-17 AP AP2011005755A patent/AP2011005755A0/xx unknown
- 2009-07-17 CN CN2009801363438A patent/CN102159233A/zh active Pending
- 2009-07-17 CA CA2750727A patent/CA2750727A1/en not_active Abandoned
- 2009-07-17 BR BRPI0924481-6A patent/BRPI0924481A2/pt not_active IP Right Cessation
- 2009-07-20 TW TW098124402A patent/TW201004640A/zh unknown
- 2009-07-20 TW TW100128455A patent/TW201138810A/zh unknown
-
2011
- 2011-01-17 CL CL2011000099A patent/CL2011000099A1/es unknown
- 2011-01-18 IL IL210715A patent/IL210715A0/en unknown
- 2011-01-18 ZA ZA2011/00461A patent/ZA201100461B/en unknown
- 2011-06-13 US US13/158,638 patent/US8802621B2/en active Active
- 2011-06-16 AR ARP110102093A patent/AR081948A2/es not_active Application Discontinuation
- 2011-06-21 IL IL213680A patent/IL213680A0/en unknown
- 2011-06-29 JP JP2011144522A patent/JP2011225596A/ja active Pending
-
2012
- 2012-07-09 US US13/544,253 patent/US20120309678A1/en not_active Abandoned
- 2012-07-27 PH PH12012501542A patent/PH12012501542A1/en unknown
-
2014
- 2014-01-30 US US14/168,849 patent/US9279010B2/en not_active Expired - Fee Related